Ennaid Therapeutics | About Us
17312
page-template-default,page,page-id-17312,ajax_fade,page_not_loaded,,qode-theme-ver-7.7,wpb-js-composer js-comp-ver-6.4.2,vc_non_responsive

About Us

Ennaid Therapeutics

Ennaid Therapeutics is developing antiviral drugs to treat COVID-19 & other coronaviruses, Zika virus, dengue virus, and other mosquito-borne illnesses using proprietary peptide inhibitors that block the entry and replication of these viruses into healthy host cells.

Ennaid Drug Development ( EDD)

Developing the world’s first therapeutic drug for all four strains of Dengue Virus

Ennaid Digital Health (EDH)

Developing Computer Vision/ Eye tracking software for use in healthcare applications.